Evaluation of Treatment Outcomes Using DNLR and GNRI in Combination Therapy with Atezolizumab and Bevacizumab for Hepatocellular Carcinoma
Evaluation of Treatment Outcomes Using DNLR and GNRI in Combination Therapy for Hepatocellular Carcinoma Background Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide, particularly in Asia. Due to its lack of early symptoms, many patients are diagnosed at an advanced stage, making surgical resection unfeasible. In r...